Ibritumomab, sometimes referred to as Zevalin, represents a innovative form of targeted radiotherapy used to manage certain types of non-Hodgkin's lymphoma , particularly previously treated follicular lymphoma cases . This is an monoclonal immune protein conjugated to Y-90 , a radioactive element th